University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Deborah Cohan, M.D.

Obstetrician and gynecologist

Dr. Deborah Cohan, an obstetrician and gynecologist, specializes in the care of pregnant women with HIV. She runs the UCSF Perinatal HIV Clinic as part of the Women's HIV Program at UCSF, is medical director of the Bay Area Perinatal AIDS Center (BAPAC) at San Francisco General Hospital and is assistant director of the National Perinatal HIV Consultation and Referral Service.

In addition to treating patients, Cohan is an associate professor in the UCSF Department of Obstetrics, Gynecology and Reproductive Sciences. Her research interests include perinatal HIV transmission, prenatal HIV testing and reproductive infectious diseases.

Cohan received a medical degree from Harvard Medical School, completed a residency in obstetrics and gynecology at UCSF and completed a fellowship in reproductive infectious diseases at San Francisco General Hospital.


HIV/AIDS Program
350 Parnassus Avenue, Suite 908
San Francisco, CA 94143
Phone: (415) 353-2119
Fax: (415) 353-2406

Hours: Monday to Thursday
8:30 a.m. – noon, 1 – 5 p.m.

Conditions & Treatments

More about Deborah Cohan

Additional Languages



Harvard School of Medicine 1996


UCSF Medical Center, Obstetrics and Gynecology 2000


San Francisco General Hospital, Reproductive Infectious Diseases 2001

Selected Research and Publications

  1. Koss CA, Natureeba P, Mwesigwa J, Cohan D, Nzarubara B, Bacchetti P, Horng H, Clark TD, Plenty A, Ruel TD, Achan J, Charlebois ED, Kamya MR, Havlir DV, Gandhi M. Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women. AIDS. 2015 Apr 24; 29(7):825-30.
  2. Cohan D, Natureeba P, Koss CA, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Gandhi M, Clark TD, Nzarubara B, Achan J, Ruel T, Kamya MR, Havlir DV. Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women. AIDS. 2015 Jan 14; 29(2):183-91.
  3. Young S, Natamba B, Luwedde F, Nyafwono D, Okia B, Osterbauer B, Natureeba P, Johnson L, Michel C, Zheng A, Robine M, Achan J, Charlebois E, Cohan D, Havlir D. "I Have Remained Strong Because of That Food": Acceptability and Use of Lipid-Based Nutrient Supplements Among Pregnant HIV-Infected Ugandan Women Receiving Combination Antiretroviral Therapy. AIDS Behav. 2014 Nov 22.
  4. Young SL, Plenty AH, Luwedde FA, Natamba BK, Natureeba P, Achan J, Mwesigwa J, Ruel TD, Ades V, Osterbauer B, Clark TD, Dorsey G, Charlebois ED, Kamya M, Havlir DV, Cohan DL. Household food insecurity, maternal nutritional status, and infant feeding practices among HIV-infected Ugandan women receiving combination antiretroviral therapy. Matern Child Health J. 2014 Nov; 18(9):2044-53.
  5. Levison J, Weber S, Cohan D. Reply to kennedy et Al. Clin Infect Dis. 2015 Feb 15; 60(4):674.
  6. Koss CA, Natureeba P, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Clark TD, Achan J, Ruel T, Nzarubara B, Kamya MR, Havlir DV, Cohan D. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Oct 1; 67(2):128-35.
  7. Natureeba P, Ades V, Luwedde F, Mwesigwa J, Plenty A, Okong P, Charlebois ED, Clark TD, Nzarubara B, Havlir DV, Achan J, Kamya MR, Cohan D, Dorsey G. Lopinavir/Ritonavir-Based Antiretroviral Treatment (ART) Versus Efavirenz-Based ART for the Prevention of Malaria Among HIV-Infected Pregnant Women. J Infect Dis. 2014 Dec 15; 210(12):1938-45.
  8. Levison J, Weber S, Cohan D. Breastfeeding and HIV-infected women in the United States: harm reduction counseling strategies. Clin Infect Dis. 2014 Jul 15; 59(2):304-9.
  9. Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, Buchbinder S. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014 Mar; 11(3):e1001613.
  10. Rahangdale L, Stewart A, Stewart RD, Badell M, Levison J, Ellis P, Cohn SE, Kempf MC, Lazenby GB, Tandon R, Rana A, Nguyen ML, Sturdevant MS, Cohan D. Pregnancy intentions among women living with HIV in the United States. J Acquir Immune Defic Syndr. 2014 Mar 1; 65(3):306-11.
  11. Bartelink IH, Savic RM, Mwesigwa J, Achan J, Clark T, Plenty A, Charlebois E, Kamya M, Young SL, Gandhi M, Havlir D, Cohan D, Aweeka F. Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda. J Clin Pharmacol. 2014 Feb; 54(2):121-32.
  12. Gandhi M, Mwesigwa J, Aweeka F, Plenty A, Charlebois E, Ruel TD, Huang Y, Clark T, Ades V, Natureeba P, Luwedde FA, Achan J, Kamya MR, Havlir DV, Cohan D. Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeeding. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):578-84.
  13. Aziz N, Sokoloff A, Kornak J, Leva NV, Mendiola ML, Levison J, Feakins C, Shannon M, Cohan D. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation. BJOG. 2013 Nov; 120(12):1534-47.
  14. Kim LH, Arinaitwe E, Nzarubara B, Kamya MR, Clark TD, Okong P, Charlebois ED, Havlir DV, Cohan D. Acceptability and feasibility of serial HIV antibody testing during pregnancy/postpartum and male partner testing in Tororo, Uganda. AIDS Care. 2014; 26(3):360-6.
  15. Weber S, Waldura JF, Cohan D. Safer conception options for HIV serodifferent couples in the United States: the experience of the National Perinatal HIV Hotline and Clinicians' Network. J Acquir Immune Defic Syndr. 2013 Aug 1; 63(4):e140-1.
  16. Ades V, Mwesigwa J, Natureeba P, Clark TD, Plenty A, Charlebois E, Achan J, Kamya MR, Havlir DV, Cohan D, Ruel TD. Neonatal mortality in HIV-exposed infants born to women receiving combination antiretroviral therapy in Rural Uganda. J Trop Pediatr. 2013 Dec; 59(6):441-6.
  17. Kim LH, Cohan DL, Sparks TN, Pilliod RA, Arinaitwe E, Caughey AB. The cost-effectiveness of repeat HIV testing during pregnancy in a resource-limited setting. J Acquir Immune Defic Syndr. 2013 Jun 1; 63(2):195-200.
  18. Cohan D, Weber S, Aaron E. CDC should reverse its recommendation against semen washing-intrauterine insemination for HIV-serodifferent couples. Am J Obstet Gynecol. 2013 Sep; 209(3):284.
  19. Cohan D, Mwesigwa J, Natureeba P, Aliba Luwedde F, Ades V, Plenty A, Kakuru A, Achan J, Clark T, Osterbauer B, Kamya M, Havlir D. WHO option B+: early experience of antiretroviral therapy sequencing after cessation of breastfeeding and risk of dermatologic toxicity. J Acquir Immune Defic Syndr. 2013 Mar 1; 62(3):e101-3.
  20. Aaron E, Cohan D. Preexposure prophylaxis for the prevention of HIV transmission to women. AIDS. 2013 Jan 2; 27(1):F1-5.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.